Open Access
Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination
Dorothy A. Machalek
1, 2, 3
,
S. Jayne Garland
2, 4
,
Julia M.L. Brotherton
3, 5
,
Deborah J. Bateson
6, 7
,
Kathleen McNamee
8, 9
,
Mary Stewart
6
,
S. J. Skinner
10
,
Bette Liu
11
,
Alyssa Cornall
1, 2, 4
,
J M Kaldor
12
,
Sepehr N. Tabrizi
1, 2, 4
5
National HPV Vaccination Program Register, Victorian Cytology Service, East Melbourne, Victoria
6
Family Planning New South Wales, Sydney
8
Family Planning Victoria, Melbourne
10
11
School of Public Health and Community Medicine
Publication type: Journal Article
Publication date: 2018-02-07
scimago Q1
wos Q1
SJR: 2.038
CiteScore: 11.1
Impact factor: 4.5
ISSN: 00221899, 15376613
PubMed ID:
29425358
Infectious Diseases
Immunology and Allergy
Abstract
A quadrivalent human papillomavirus vaccination program targeting females aged 12-13 years commenced in Australia in 2007, with catch-up vaccination of 14-26 year olds through 2009. We evaluated the program's impact on HPV prevalence among women aged 18-35 in 2015.HPV prevalence among women aged 18-24 and 25-35 was compared with prevalence in these age groups in 2005-2007. For women aged 18-24, we also compared prevalence with that in a postvaccine study conducted in 2010-2012.For the 2015 sample, Vaccination Register-confirmed 3-dose coverage was 53.3% (65.0% and 40.3% aged 18-24 and 25-35, respectively). Prevalence of vaccine HPV types decreased from 22.7% (2005-2007) and 7.3% (2010-2012), to 1.5% (2015) (P trend < .001) among women aged 18-24, and from 11.8% (2005-2007) to 1.1% (2015) (P = .001) among those aged 25-35.This study, reporting the longest surveillance follow-up to date, shows prevalence of vaccine-targeted HPV types has continued to decline among young women. A substantial fall also occurred in women aged 25-35, despite lower coverage. Strong herd protection and effectiveness of less than 3 vaccine doses likely contributed to these reductions.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Vaccine
15 publications, 12.1%
|
|
|
Vaccines
5 publications, 4.03%
|
|
|
Papillomavirus Research
4 publications, 3.23%
|
|
|
Expert Review of Vaccines
4 publications, 3.23%
|
|
|
Journal of Infectious Diseases
4 publications, 3.23%
|
|
|
BMJ Open
4 publications, 3.23%
|
|
|
Communicable Diseases Intelligence
4 publications, 3.23%
|
|
|
Gynecologic Oncology
3 publications, 2.42%
|
|
|
Pediatrics
2 publications, 1.61%
|
|
|
Health Expectations
2 publications, 1.61%
|
|
|
BMC Cancer
2 publications, 1.61%
|
|
|
BMC Infectious Diseases
2 publications, 1.61%
|
|
|
PLoS ONE
2 publications, 1.61%
|
|
|
The Lancet Public Health
2 publications, 1.61%
|
|
|
La Revue de Santé Scolaire et Universitaire
2 publications, 1.61%
|
|
|
Actualites Pharmaceutiques
2 publications, 1.61%
|
|
|
Journal of Gynecology Obstetrics and Human Reproduction
2 publications, 1.61%
|
|
|
International Journal of Cancer
2 publications, 1.61%
|
|
|
Human Vaccines and Immunotherapeutics
2 publications, 1.61%
|
|
|
Epidemiology and Vaccinal Prevention (Epidemiologiya i Vaktsinoprofilaktika)
2 publications, 1.61%
|
|
|
Annals of Internal Medicine
1 publication, 0.81%
|
|
|
Emerging Infectious Diseases
1 publication, 0.81%
|
|
|
Sexual Health
1 publication, 0.81%
|
|
|
Journal of Women's Health
1 publication, 0.81%
|
|
|
Journal of Lower Genital Tract Disease
1 publication, 0.81%
|
|
|
Medicine (United States)
1 publication, 0.81%
|
|
|
International Journal of Environmental Research and Public Health
1 publication, 0.81%
|
|
|
Viruses
1 publication, 0.81%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 publication, 0.81%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Elsevier
45 publications, 36.29%
|
|
|
Wiley
11 publications, 8.87%
|
|
|
Springer Nature
9 publications, 7.26%
|
|
|
MDPI
8 publications, 6.45%
|
|
|
Taylor & Francis
8 publications, 6.45%
|
|
|
Oxford University Press
8 publications, 6.45%
|
|
|
BMJ
4 publications, 3.23%
|
|
|
Australian Government Department of Health and Aged Care
4 publications, 3.23%
|
|
|
American Academy of Pediatrics
2 publications, 1.61%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.61%
|
|
|
Frontiers Media S.A.
2 publications, 1.61%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.61%
|
|
|
LLC Numicom
2 publications, 1.61%
|
|
|
American College of Physicians
1 publication, 0.81%
|
|
|
Centers for Disease Control and Prevention (CDC)
1 publication, 0.81%
|
|
|
CSIRO Publishing
1 publication, 0.81%
|
|
|
Mary Ann Liebert
1 publication, 0.81%
|
|
|
Korean Association of Urogenital Tract Infection and Inflammation
1 publication, 0.81%
|
|
|
Slovenian Medical Society
1 publication, 0.81%
|
|
|
European Centre for Disease Control and Prevention (ECDC)
1 publication, 0.81%
|
|
|
Deutscher Arzte-Verlag GmbH
1 publication, 0.81%
|
|
|
AME Publishing Company
1 publication, 0.81%
|
|
|
Societe Francaise de Sante Publique
1 publication, 0.81%
|
|
|
XMLink
1 publication, 0.81%
|
|
|
Paediatrician Publishers LLC
1 publication, 0.81%
|
|
|
Baishideng Publishing Group
1 publication, 0.81%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
124
Total citations:
124
Citations from 2024:
21
(16.93%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Machalek D. A. et al. Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination // Journal of Infectious Diseases. 2018. Vol. 217. No. 10. pp. 1590-1600.
GOST all authors (up to 50)
Copy
Machalek D. A., Garland S. J., Brotherton J. M., Bateson D. J., McNamee K., Stewart M., Skinner S. J., Liu B., Cornall A., Kaldor J. M., Tabrizi S. N. Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination // Journal of Infectious Diseases. 2018. Vol. 217. No. 10. pp. 1590-1600.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1093/infdis/jiy075
UR - https://doi.org/10.1093/infdis/jiy075
TI - Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination
T2 - Journal of Infectious Diseases
AU - Machalek, Dorothy A.
AU - Garland, S. Jayne
AU - Brotherton, Julia M.L.
AU - Bateson, Deborah J.
AU - McNamee, Kathleen
AU - Stewart, Mary
AU - Skinner, S. J.
AU - Liu, Bette
AU - Cornall, Alyssa
AU - Kaldor, J M
AU - Tabrizi, Sepehr N.
PY - 2018
DA - 2018/02/07
PB - Oxford University Press
SP - 1590-1600
IS - 10
VL - 217
PMID - 29425358
SN - 0022-1899
SN - 1537-6613
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2018_Machalek,
author = {Dorothy A. Machalek and S. Jayne Garland and Julia M.L. Brotherton and Deborah J. Bateson and Kathleen McNamee and Mary Stewart and S. J. Skinner and Bette Liu and Alyssa Cornall and J M Kaldor and Sepehr N. Tabrizi},
title = {Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination},
journal = {Journal of Infectious Diseases},
year = {2018},
volume = {217},
publisher = {Oxford University Press},
month = {feb},
url = {https://doi.org/10.1093/infdis/jiy075},
number = {10},
pages = {1590--1600},
doi = {10.1093/infdis/jiy075}
}
Cite this
MLA
Copy
Machalek, Dorothy A., et al. “Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination.” Journal of Infectious Diseases, vol. 217, no. 10, Feb. 2018, pp. 1590-1600. https://doi.org/10.1093/infdis/jiy075.